Question two of two

Who pays

The share of health spending that is public money — a different variable from who owns the hospitals, and one with much broader country coverage. The United States ranks 73rd of 156.

156 countries World Bank WDI Financing, not ownership

Keep the two questions apart

This page: who pays the bills. Government share of current health expenditure, whoever owns the provider that receives the money.

The public ownership page: who owns the delivery apparatus. Hospitals, beds, care homes, drug manufacturing.

Conflating the two is the most common mistake in this debate. They correlate at only r = +0.25 — see the comparison below.

Public share of health financing

Government share of current health expenditure · World Bank, 156 countries

Public share of health spending

Top 20 of 156 · the United States shown in position

Four of the top ten are Gulf oil states whose outcome figures are not comparable (see Method), though their financing shares are real. Excluding them, the genuine top ten is Norway, Sweden, Japan, Czechia, Croatia, Denmark, Cuba, the UK, Finland and Germany.

World Bank WDI, 2023–24. The United States funds 54% of its health care publicly — a smaller share than Mexico, Türkiye or Colombia.
#	Country	Public share	Out-of-pocket

A counterintuitive number — do not misread it

America's out-of-pocket share (10.9%) looks low, better than Denmark's 13.9%. That is an accounting artifact, not a benefit. Insurance premiums are not counted as out-of-pocket in this series — only payments made at the point of service. American cost burden shows up as premiums and deductibles, which this metric does not capture at all.

What public financing relates to

Tested against outcomes, cost and financial protection · and the confound that ruins the obvious answer

The obvious chart — public share of spending against health outcomes, all countries — shows a strong positive relationship: r = +0.72. Countries that fund health publicly are healthier. It is tempting to stop there.

Don't. Over the same 155 countries, GDP per capita predicts health outcomes better — r = +0.80. Rich countries both fund publicly and are healthy, for reasons that start with being rich.

Among rich countries, what does a bigger public share buy?

35 advanced nations split into thirds by public share of health spending · group averages

Restricting to advanced nations removes the income confound almost entirely — and the outcome differences largely disappear with it. The highest-public third spends slightly less per person than the lowest ($5,921 against $6,099) and scores marginally better. Neither gap is meaningful at this sample size. The third column is the one that moves.

Public financing against out-of-pocket burden

35 advanced nations · dashed line is the least-squares fit

The strongest and most robust relationship in the whole dataset: r = −0.64, comfortably significant at n = 35. Every ten percentage points of public financing is associated with roughly five fewer percentage points falling directly on patients. Greece and South Korea push a third of all health costs onto households at the point of service.

What public financing does and does not buy

Health outcomes, globally: a real positive relationship (partial r = +0.44 controlling for income), roughly half the size the raw +0.72 suggests.
Health outcomes, among rich countries: no detectable relationship (r = +0.15, not significant).
Efficiency: no relationship among advanced nations (r = −0.02).
Financial protection: strong and robust (r = −0.64). This is what public financing reliably changes.

The case this supports is not "public financing makes people live longer than private financing does in comparably rich countries." It is that public systems deliver equivalent outcomes at equivalent cost while dramatically reducing what sick people pay at the moment they need care.

Financing and ownership are two different axes

The single most useful finding on either page

Public financing and public ownership of delivery are routinely treated as one thing — "socialised medicine." Across the 39 countries where both can be measured, they correlate at only r = +0.25. Knowing how a country pays tells you very little about who owns its hospitals.

Public financing against public delivery ownership

39 countries · the dashed line is the fit; a country on the diagonal would fund and own to the same degree

The upper-left region — high public financing, low public ownership — is crowded. These are countries where government pays private and non-profit providers: Japan, the Netherlands, Germany, Australia, South Korea, Belgium. The lower-right is nearly empty: almost nobody owns the delivery system without also paying for it.

Positive gap = pays publicly, owns privately. Negative gap = owns more than it funds. Japan tops the list at +71.4 points: a system that is almost entirely publicly financed and almost entirely privately owned.
#	Country	Public financing	Public delivery ownership	Gap

Why this matters for any argument about health policy

The four canonical combinations all exist in the real world, and they perform differently on different measures:

Public money, public providers — the Nordics, Croatia, Slovenia, Costa Rica. Strong financial protection, lower spending.
Public money, private providers — Japan, the Netherlands, Germany, Canada's physician sector. Excellent outcomes, strong financial protection, higher spending.
Private money, public providers — rare, and mostly transitional. Chile and several post-socialist states lean this way.
Private money, private providers — the United States, and to a lesser degree South Korea and Greece. The most expensive combination on record.

Japan is the case that should trouble everyone: 84.8% public financing, 13.4% public ownership, the best health outcomes in the world, at 40% of American spending. Public payment plus private delivery is not a contradiction, and on this evidence it is not a weakness either.

References

Every source used on this page · switch style, then copy individually or all at once